Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients

Objective： The aim of this study was to detect metastasis-associated in colon cancer-1 （MACC1） expression in Chinese gastric cancer and analyze the relationship between MACC1 expression and postoperative survival. Methods： The expression of MACC1 and c-MET protein in a sample of 128 gastric cancer tissues was detected by immunohistochemistry. A retrospective cohort study on the prognosis was carried out and data were collected from medical records. Results： The positive rate of MACC1 protein expression in gastric cancer was 47.66%, higher than that in adjacent noncancerous mucosa （P0.001）. MACC1 protein expression was not related to the clinicopathological variables involved. Kaplan-Meier analysis revealed that the survival of MACC1 positive group tended to be better than that of MACC1 negative group, particularly in patients with stage III carcinoma （P=0.032）. Cox regression analysis revealed that MACC1 protein over-expression in gastric cancer tended to be a protective factor with hazard ratio of 0.621 （P=0.057）. Immunohistochemical analysis showed that the positive rate of c-MET protein expression was much higher in cases with positive MACC1 expression in gastric cancer （P=0.002）, but P53 expression was not associated with MACC1 expression. Conclusion： MACC1 over-expression implies better survival and may be an independent prognostic factor for gastric cancer in Chinese patients.

Prognostic value of YKL-40 in colorectal carcinoma patients:A metaanalysis

BACKGROUND In recent years,the predictive role of YKL-40 for long-term survival in colorectal cancer patients has been gradually investigated.However,whether it is a reliable and valuable prognostic indicator for patients with colorectal carcinoma has not been verified.AIM To identify the prognostic value of serum/plasma concentration of YKL-40 or expression status of YKL-40 in tumor cells in colorectal carcinoma patients.METHODS Several electronic databases including the PubMed,EMBASE,Web of Science,CNKI,VIP and WanFang were searched for relevant studies.The hazard ratios(HR)and 95%confidence intervals(CI)were combined and the primary and secondary outcomes were overall survival(OS)and progression-free survival(PFS),respectively.All statistical analysis were conducted by STATA 15.0 software.RESULTS A total of nine studies involving 2545 patients were included.The pooled results indicated that YKL-40 was significantly associated with poor OS(HR=1.80,95%CI:1.32-2.45,P<0.001)and PFS(HR=1.62,95%CI:1.22-2.16,P=0.001).Subgroup analysis stratified by the treatment,tumor type and source of YKL-40 showed similar results.CONCLUSION Elevated serum/plasma concentration of YKL-40 or positive expression in tumor cells was related with worse prognosis of colorectal carcinoma patients.YKL-40 might serve as a novel and reliable indicator for the evaluation of prognosis in colorectal cancer.

Correlation of annexin A2 expression with epithelial-mesenchymal transition and extracellular matrix degradation in bile duct carcinoma

Objective: To investigate the correlation of annexin A2 expression with epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) degradation in bile duct carcinoma. Methods: A total of 60 patients with primary bile duct carcinoma who accepted bile duct carcinoma laparotomy in our hospital between April 2009 and May 2017 were selected. The bile duct carcinoma tissue and adjacent normal tissue were kept during operation and enrolled in bile duct cancer group (n=60) and normal control group (n=60). The protein expression of annexin A2, EMT marker molecules, MMPs subtypes and TIMPs subtypes in two groups of specimens were detected, and Pearson test was used to evaluate the correlation of annexin A2 expression with EMT and ECM degradation in bile duct carcinoma tissue. Results: Annexin A2 expression in bile duct cancer group was higher than that in normal control group;E-cadherin, β-catenin and syndecan-1 protein expression in bile duct cancer group were lower than those in control group whereas P-cadherin and Vimentin protein expression were higher than those in normal control group;MMP-2, MMP-7 and MMP-9 protein expression in bile duct cancer group were higher than those in normal control group whereas TIMP-1 and TIMP-2 protein expression were lower than those in normal control group. Pearson test showed that the annexin A2 expression in bile duct carcinoma was directly correlated with the protein expression of EMT marker molecules, MMPs subtypes and TIMPs subtypes. Conclusion: annexin A2 increases in bile duct carcinoma, and it can regulate EMT and ECM degradation process to affect the disease outcome.

Laparoscopic Omohyoid Muscle Transection Surgery： A Novel Procedure Against Omohyoid Muscle Syndrome

Omohyoid muscle syndrome （OMS）, also called omohyoid sling syndrome, is a rare disease. The first OMS case was reported in 1980. OMS is presented by a mass without pain on the neck when the patient swallows and disappears after swallow. The patient often feels discomfort and dysphasia when the mass appears.